Cervomed Inc (CRVO) Live Share Price, Invest From India

Cervomed Inc Stock Performance

as on March 25, 2026 at 1:06 am IST

Day's High
$4.00
Day's Price Range
$4.05
$4.00
1.25%
Upside
52 Week's Low
52 Week's High
$3.58
52-Week Price Range
$14.97
$4.00
10.50%
Downside
274.19%
Upside

Cervomed Inc share price movements today

Previous Close: $4.02
Open: $4.05
Volume: 132.3K
Day's Low - High: $4.00 - $4.05
52 Week Low - High: $3.58 - $14.97

Cervomed Inc Historical Returns

1 Month Return: -13.36 %
3 Month Return: -52.26 %
1 Year Return: -71.87 %
3 Year Return: 0 %
5 Year Return: 0 %

Cervomed Inc Stock Fundamentals & Key Indicators

Check Cervomed Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$37.2M

EPS (TTM)

-2.3843

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

Revenue (TTM)

4.0M

Profit Margin

0.00%

Return On Equity TTM

-93.92%

Cervomed Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cervomed Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cervomed Inc	BUY	$37.2M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$41.4B	125.13%	133.41	8.45%
Vertex Pharmaceuticals Incorporated	BUY	$115.3B	112.56%	29.67	32.94%
Beone Medicines Ltd	NA	$31.6B	NA	111	5.37%
Regeneron Pharmaceuticals, Inc.	BUY	$77.5B	56.01%	17.67	31.41%

Stock Returns calculator for Cervomed Inc Stock including INR - Dollar returns

The Cervomed Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Cervomed Inc investment value today

Current value as on today

₹37,532

Returns

₹62,468

(-62.47%)

Returns from Cervomed Inc Stock

₹72,008 (-72.01%)

Dollar Returns*

₹9,541 (+9.54%)

Analyst Recommendation on Cervomed Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Cervomed Inc. Average target price of $22.14

Cervomed Inc Share Price Target

Get share price movements and forecasts by analysts on Cervomed Inc.

What analysts predicted

81.93%UPSIDE

Target Price

$22.14

Current Price

Analyzed by

7 Analysts

Target

$22.14

Cervomed Inc target price $22.14, a slight upside of 81.93% compared to current price of $4. According to 7 analysts rating.

Cervomed Inc Stock’s Investor Sentiment and Interest

Search interest for Cervomed Inc Stock has increased by 25% in the last 30 days, reflecting an upward trend in search activity.

Time period: February 22, 2026 to March 24, 2026

Change:25% versus previous 30 day period

Cervomed Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	1	2	2	3	1	2	1	1	0	0
Gross Profit	0	0	0	3	-3	-4	-2	-3	0	-
Operating Income	-2	-2	-2	-2	-5	-7	-5	-6	-8	-8
EBITDA	-2	3	-2	-2	-5	-7	-5	-6	-7	-8
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	2	-2	-2	-2	-4	-6	-4	-6	-7	-8
Income Tax Expense	-2	0	0	0	-	-	-	-	-	-
Net Income	2	-2	-2	-2	-4	-6	-4	-6	-7	-8
Net Profit Margin	140.91%	-94.84%	-107.13%	-70.44%	-245.03%	-310.17%	-255.30%	-356.05%	-2395.34%	-92680.37%

Cervomed Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	7	9	4
Gross Profit	0	0	0	-1	-1	-9	-
Operating Income	-11	-15	-24	-15	-7	-18	-28
EBITDA	-11	-15	-15	-3	-7	-18	-28
Interest Expense	-	-	-	0	-	-	-
Depreciation	0	0	0	0	-	-	-
Income Before Tax	-11	-15	-24	-15	-2	-16	-26
Income Tax Expense	0	-1	0	-3	0	-	-
Net Income	-11	-14	-24	-15	-2	-16	-26
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-30.40%	-167.29%	-673.06%

Cervomed Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-2	-2	-2	-4	-6	-4	-6	-7	-8
Operating Cash Flow	-2	-1	-2	-4	-8	-3	-6	-6	-6
Investing Cash Flow	-	-	-40	2	9	5	0	7	5
Financing Cash Flow	0	-	46	0	-	-	4	-	-
Change in Cash	-2	-1	3	-2	1	1	-2	1	-1

Cervomed Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-1	-18	-11	-14	-24	-5	-2	-16	-26
Operating Cash Flow	-12	-10	-9	-13	-14	-2	-7	-16	-23
Investing Cash Flow	0	-	-	-	0	-12	-	-28	18
Financing Cash Flow	20	9	16	17	33	0	11	46	4
Change in Cash	7	0	6	4	18	-33	3	1	0

Insights on Cervomed Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 11.4% return, outperforming this stock by 73.9%
NEGATIVE IMPACT
Price Dip
In the last 7 days, CRVO stock has moved down by -11.3%

About Cervomed Inc

diffusion pharmaceuticals is a clinical stage company focused on improving the effectiveness of standard-of-care therapies for life-threatening treatment-resistant solid cancerous tumors, without adding harmful side effects. the company is developing its lead drug, trans sodium crocetinate (tsc), which has received orphan drug designation from the fda for use in a number of cancers in which tumor hypoxia (oxygen deprivation) diminishes the efficacy of current treatments. tsc targets the cancer’s hypoxic micro-environment, re-oxygenating treatment-resistant tissue and making the cancerous cells more vulnerable to the therapeutic effects of conventional radiation and chemotherapy. the company is poised to begin a pivotal phase 3 trial in glioblastoma (gbm) in 2016. other programs include planned phase 2/3 trials in pancreatic cancer and brain metastases. because tsc’s novel mechanism safely re-oxygenates a wide range of tumor types, its use is not limited to a specific tumor tissue, but

Organisation	Cervomed Inc
Headquarters	20 Park Plaza, Boston, MA, United States, 02116
CEO	Dr. John J. Alam M.D.
E-voting on shares	Click here to vote

Key Management of Cervomed Inc

Name	Title
Dr. Matthew Winton Ph.D.	Chief Commercial & Business Officer
Dr. John J. Alam M.D.	Co-Founder, CEO, President & Director
Dr. Sylvie L. Gregoire Pharm.D.	Co-Founder & Director
Mr. William Robert Elder J.D.	CFO, General Counsel & Corporate Secretary
Dr. Marinus Verwijs Ph.D.	Executive Vice President of Technical Operations
Ms. Kelly Blackburn M.H.A.	Executive Vice President of Clinical Development
Dr. Mark A. De Rosch Ph.D.	Executive VP of Regulatory, Government Affairs & Program Management
Dr. Claudia Ordonez M.D.	Senior Vice President of Medical Science

FAQs

What is Cervomed Inc share price today?

Cervomed Inc share price today is $4 as on March 24, 2026 at 7:36 pm IST. Cervomed Inc share today touched a day high of $4.05 and a low of $4.

What is the 52 week high and 52 week low for Cervomed Inc share?

Cervomed Inc share touched a 52 week high of $14.97 on March 24, 2025 and a 52 week low of $3.58 on February 27, 2026. Cervomed Inc stock price today i.e. March 24, 2026 at 7:36 pm IST is trending at $4,which is 73.28% down from its 52 week high and 11.73% up from its 52 week low.

What is Cervomed Inc's market capitalisation today?

Cervomed Inc market capitalisation is $0.00T as on March 24, 2026 at 7:36 pm IST.

How to invest in Cervomed Inc Stock (CRVO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cervomed Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cervomed Inc Shares that will get you 0.3750 shares as per Cervomed Inc share price of $4 per share as on March 24, 2026 at 7:36 pm IST.

What is the minimum amount required to buy Cervomed Inc Stock (CRVO) from India?

Indian investors can start investing in Cervomed Inc (CRVO) shares with as little as ₹93.734 or $1 (as of March 24, 2026 at 7:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹937.34 in Cervomed Inc stock (as per the Rupee-Dollar exchange rate as on March 24, 2026 at 7:42 pm IST). Based on Cervomed Inc share’s latest price of $4 as on March 24, 2026 at 7:36 pm IST, you will get 2.5000 shares of Cervomed Inc. Learn more about fractional shares .